Article
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease
5 Apr 2022
Abstract excerpt
BACKGROUND: Myxopapillary ependymoma (MPE) is a heterogeneous disease regarding histopathology and outcome. The underlying molecular biology is poorly understood, and markers that reliably predict the patients' clinical course are unknown. METHODS: We assembled a cohort of 185 tumors classified as MPE based on DNA methylation. Methylation patterns, copy number profiles, and MGMT promoter methylation were analyzed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
